Abstract:Abnormal glycan structures are valuable biomarkers for disease states; the development of glycan-specific binders is thereby significantly important. However, the structural homology and weak immunogenicity of glycans pose major hurdles in the evolution of antibodies, while the poor availability of complex glycans also has extremely hindered the selection of anti-glycan aptamers. Herein, we present a new approach to efficiently screen aptamers toward specific glycans with a complex structure, using a glycosylated peptide as a scaffold. In this method, using peptide-imprinted magnetic nanoparticles (MNPs) as a versatile platform, a glycopeptide tryptically digested from a native glycoprotein was selectively entrapped for positive selection, while a nonglycosylated analogue with an identical peptide sequence was synthesized for negative selection. Alternating positive and negative selection steps were carried out to guide the directed evolution of glycan-binding aptamers. As proof of the principle, the biantennary digalactosylated disialylated <i>N</i>-glycan A2G2S2, against which there have been no antibodies and lectins so far, was employed as the target. With the glycoprotein transferrin as a source of target glycan, two satisfied anti-A2G2S2 aptamers were selected within seven rounds. Since A2G2S2 is upregulated in cancerous liver cells, carboxyfluorescein (FAM)-labeled aptamers were prepared as fluorescent imaging reagents, and successful differentiation of cancerous liver cells over normal liver cells was achieved, which demonstrated the application feasibility of the selected aptamers. This approach obviated a tedious glycan preparation process and allowed favorable expose of the intrinsic flexible conformation of natural glycans. Therefore, it holds great promise for developing glycan-specific aptamers for challenging applications such as cancer targeting.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c03675?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c03675</a>.Experimental details; MALDI-TOF MS spectra; characterization of BA-MNPs; structures of the silylating monomers; FI-IR spectra; the selectivity of peptide-imprinted MNPs; predicted secondary structures of the aptamers; binding affinity measurement of the candidate aptamers; the specificity test; modified and unmodified ssDNA sequences; SELEX screening conditions; and sequences of aptamer candidates (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c03675/suppl_file/ac0c03675_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Phage Display Screening Against A Set of Targets to Establish Peptide-Based Sugar Mimetics and Molecular Docking to Predict Binding Site

Screening and Identification of A Targeting Peptide to Nglp-1r from Phage Display Peptide Library

Peptide Phage Display as a Tool for Drug Discovery: Targeting Membrane Receptors

A Computational and Chemical Design Strategy for Manipulating Glycan‐Protein Recognition

Identification of Insulin Mimetics from a Phage-displayed Library

Identification of highly selective covalent inhibitors by phage display

Exploiting Phage Display for Development of Novel Cellular Targeting Strategies

Phage Display of Two Distinct Warheads to Inhibit Challenging Proteins.

Sortase-Mediated Peptide Ligation and Cyclization for Phage Display

Phage display based biosensing: Recent advances and challenges

Selection of Human Stem Cell Factor Mimetic Peptides from Phage-Displayed Random Peptide Library

Identification of New Peptide Ligands for Epidermal Growth Factor Receptor Using Phage Display and Computationally Modeling their Mode of Binding

Identification of peptide mimetics of xenoreactive α-Gal antigenic epitope by phage display

Modification of phage display technique for improved screening of high-affinity binding peptides

PHASTpep: Analysis Software for Discovery of Cell-Selective Peptides via Phage Display and Next-Generation Sequencing

Using NGS to Uncover the Corruption of a Peptide Phage Display Selection

Efficient Screening of Glycan-Specific Aptamers Using a Glycosylated Peptide as a Scaffold

Identification of peptide mimetics of xenoreactive alpha-Gal antigenic epitope by phage display.

Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking

An integrated platform approach enables discovery of potent, selective and ligand-competitive cyclic peptides targeting the GIP receptor

Selecting peptide ligands of microcystin-LR from phage displayed random libraries